News
Video
Podcasts
Journals
Conferences
Events
Resources
CE
About AJMC
Subscribe

Spotlight -

Free In-Person Regional Events Focused on Oncology and Population Health

Natalia Petruski-Ivleva, PhD

Articles by Natalia Petruski-Ivleva, PhD

ACE Inhibitor or ARB Treatment Among Patients With Diabetes and Chronic Kidney Disease

ByLinda F. Fried, MD, MPH,Natalia Petruski-Ivleva, PhD,Kerstin Folkerts, MSc,Niklas Schmedt, DrPH,Priscilla Velentgas, PhD,Csaba P. Kovesdy, MD

December 8th 2021

eAppendix: ACE Inhibitor or ARB Treatment Among Patients With Diabetes and Chronic Kidney Disease

ByLinda F. Fried, MD, MPH,Natalia Petruski-Ivleva, PhD,Kerstin Folkerts, MSc,Niklas Schmedt, DrPH,Priscilla Velentgas, PhD,Csaba P. Kovesdy, MD

December 8th 2021

Latest Updated Articles

ACE Inhibitor or ARB Treatment Among Patients With Diabetes and Chronic Kidney Disease
Published: December 8th 2021 | Updated:
eAppendix: ACE Inhibitor or ARB Treatment Among Patients With Diabetes and Chronic Kidney Disease
Published: December 8th 2021 | Updated:

Trending on AJMC

FDA Approves Nerandomilast for Idiopathic Pulmonary Fibrosis

HMA Combination Therapy Boosts Survival in Accelerated- or Blast-Phase MPNs

259 Prospect Plains Rd, Bldg H
Monroe, NJ 08831

© 2025 MJH Life Sciences^®

All rights reserved.